COMPARATIVE EFFICACY OF ANTIBODIES TO C-TERMINAL FRAGMENT OF BETA-SUBUNIT INSULIN RECEPTOR IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
- 作者: Rogova NV1, Kulicova IV1, Stacenko VI1, Ryazanova AU1, Sergeeva SA1, Epshtein OI1
-
隶属关系:
- 期: 卷 8, 编号 1 (2011)
- 页面: 26-28
- 栏目: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/118220
- ID: 118220
如何引用文章
全文:
详细
At the end of study it was established that a 6-month combined therapy (metformin 850 mg twice daily and extremely low doses of antibodies to the C-final fragment of insulin receptor 2 tablets 4 times daily) allowed a maintenance of an adequate glycemic control of glucose levels in patients with type 2 diabetes.
参考
- Галстян Г. Р. // Consilium Medicum. - 2008. - Т. 10, № 9 - С. 44-155.
- Шестакова М. В. // Consilium Medicum. - 2009. - Т. 11, № 12 - С. 341-350.
- Эпштейн О. И. Сверхмалые дозы. История одного исследования. - М., 2008. - 336 с.
补充文件
